| abstract |
Pyridothienotriazines as antiangiogenic compounds. The present invention concerns derivatives of pyridothienotriazines with antiangiogenic activity and use thereof in the preparation of pharmaceutical compositions or medicines for the treatment of diseases involving the angiogenesis process, such as cancer, obesity, diabetic retinopathias, haemangomas, arthritis, psoriasis and atherosclerosis. |